CD27: A Biomarker for Progression to MS? CD27: A Biomarker for Progression to MS?

Levels of soluble CD27 in cerebrospinal fluid could be used to help gauge which patients with a first demyelinating attack will develop MS and how aggressive their disease may be, a new study suggests.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news